FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics and genecology, and can be used in prediction of developing arterial hypertension in the second and third trimesters of pregnancy. That is ensured by measuring arterial pressure in the second trimester of pregnancy. Mean arterial pressure is determined in the second trimester of pregnancy. An average value between the diastolic and systolic values is determined by the original design formula. If average BP is in the third trimester of pregnancy >100 mm Hg. predicting development of gestational arterial hypertension.
EFFECT: method provides an affordable and not requiring additional means of predicting the development of arterial hypertension during pregnancy.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING THE RISK OF DEVELOPING ARTERIAL HYPERTENSION INDUCED BY PREGNANCY | 2016 |
|
RU2649467C1 |
| METHOD FOR PREDICTION OF PERSISTENT BLOOD PRESSURE INCREASE OVER PERIOD OF PREGNANCY IN WOMEN WITH PRIMARY HYPERTENSION | 2009 |
|
RU2410020C2 |
| METHOD FOR PREDICTING CEREBRAL ISCHEMIA IN NEWBORNS BORN TO MOTHERS WITH PREECLAMPSIA | 2021 |
|
RU2777225C1 |
| DIAGNOSTIC TECHNIQUE FOR FUNCTIONAL CHANGES OF VASOACTIVE STATUS OF PREGNANT WOMAN IN EARLY PREECLAMPSIA | 2023 |
|
RU2825534C1 |
| METHOD OF PREDICTING DEGREE OF HYPOTENSIVE EFFECT OF DRUG THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2023 |
|
RU2806479C1 |
| METHOD OF PREDICTING LEVEL OF ARTERIAL PRESSURE IN WOMEN IN LATE PREGNANCY | 2014 |
|
RU2557944C1 |
| METHOD FOR PREDICTION OF BLOOD PRESSURE IN DELIVERING FEMALES WITH USING 4a/4b eNOS GENETIC POLYMORPHISM | 2014 |
|
RU2565405C1 |
| DIAGNOSTIC TECHNIQUE FOR PREECLAMPSIA | 2014 |
|
RU2567821C1 |
| METHOD OF PREDICTING THE RISK OF PRE-ECLAMPSIA IN PREGNANT WOMEN WITH TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2800716C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PROTHROMBOTIC CHANGES IN ADOLESCENTS WITH ESSENTIAL ARTERIAL HYPERTENSION | 2013 |
|
RU2514887C1 |
